Bardoxolone (CDDO)

Bardoxolone (CDDO), acts by releasing Nrf2 from KEAP1,is a highly potent activator of Nrf2 that induce programmed cell death (apoptosis) in cancer cells.

Price Not Available 25mg Bardoxolone (CDDO) Supplier Page

Trivial name	RTA 401
Catalog Number	S6647
Molecular Formula	C31H41NO4
CAS#	218600-44-3
Inchi	InChI=1S/C31H41NO4/c1-26(2)10-12-31(25(35)36)13-11-30(7)23(19(31)16-26)20(33)14-22-28(5)15-18(17-32)24(34)27(3,4)21(28)8-9-29(22,30)6/h14-15,19,21,23H,8-13,16H2,1-7H3,(H,35,36)/t19-,21-,23-,28-,29+,30 +,31-/m0/s1
Inchi Key	TXGZJQLMVSIZEI-UQMAOPSPSA-N
SMILES	CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)C(=O)O)C
Size	25mg
Supplier Page	http://www.selleckchem.com/products/bardoxolone.html
Additional Information	https://file.selleck.cn/downloads/struct/bardoxolone-chemical-structure-s6647.gif